4.5 Article

Alterations Within the Osteo-Hematopoietic Niche in MDS and their Therapeutic Implications

期刊

CURRENT PHARMACEUTICAL DESIGN
卷 22, 期 16, 页码 2323-2332

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612822666160226132914

关键词

Osteo-hematopoietic niche; MDS; bone marrow; HSPC; MSPC; TGF-beta; signaling

资金

  1. German Cancer Consortium
  2. Jose Carreras Foundation
  3. German Research Foundation

向作者/读者索取更多资源

Hematopoietic and mesenchymal stem and progenitor cells are organized in the osteo-hematopoietic niche, a complex microenvironment ensuring self-renewal and differentiation. Perturbations of the niche architecture, the mutual cellular interactions and signaling pathways disrupt tissue homeostasis resulting in cytopenia and malignant diseases such as myelodysplastic syndromes (MDS), supporting the concept of niche-induced oncogenesis. Analyzing the available treatment options for patients harboring MDS, it becomes evident that many of them specifically modify components of the stem cell niche. Hereby especially compounds inhibiting the TGF-beta superfamily seem to represent a promising novel approach for patients with anemia as a result of ineffective erythropoiesis. Moreover, apart from affecting tumorigenesis, these drugs appear to influence bone structure and function as well as hematopoiesis in elderly MDS patients with a disturbed microarchitecture of the bone marrow. In the present review we will dissect the contribution of components of the stem cell niche for the pathogenesis of MDS and discuss current therapeutic strategies targeting components of the niche, focusing on the modulation of TGF-beta signaling.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Endocrinology & Metabolism

Skeletal health in patients following allogeneic hematopoietic cell transplantation

Tilman D. Rachner, Cornelia S. Link-Rachner, Martin Bornhaeuser, Lorenz C. Hofbauer

Summary: Patients who undergo allogeneic hematopoietic cell transplantation (HCT) are at an increased risk of developing bone loss due to various factors, including the disease itself and the applied therapies. This review provides an overview of the underlying mechanisms and offers screening and treatment recommendations for managing this complication.
Article Endocrinology & Metabolism

Genetic Diagnostics in Routine Osteological Assessment of Adult Low Bone Mass Disorders

Ralf Oheim, Elena Tsourdi, Lothar Seefried, Gisela Beller, Max Schubach, Eik Vettorazzi, Julian Sturznickel, Tim Rolvien, Nadja Ehmke, Alena Delsmann, Franca Genest, Ulrike Krueger, Tomasz Zemojtel, Florian Barvencik, Thorsten Schinke, Franz Jakob, Lorenz C. Hofbauer, Stefan Mundlos, Uwe Kornak

Summary: The impact of genetic testing on the differential diagnosis of adult LBMD was investigated in this study. Clinical criteria for predicting monogenic forms were also defined. The results showed that genetic testing can easily distinguish overlapping spectra of monogenic adult LBMD, and the proposed clinical criteria can help maximize the diagnostic yield.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Review Endocrinology & Metabolism

Bone fragility in diabetes: novel concepts and clinical implications

Lorenz C. Hofbauer, Bjoern Busse, Richard Eastell, Serge Ferrari, Morten Frost, Ralph Mueller, Andrea M. Burden, Fernando Rivadeneira, Nicola Napoli, Martina Rauner

Summary: Increased fracture risk is a serious complication of diabetes, leading to prolonged immobility and hospitalizations that can result in significant morbidity and mortality. In type 1 diabetes, bone mass and strength are reduced, leading to a five-fold increased risk of lifelong fractures. In type 2 diabetes, fracture risk is increased despite normal bone mass. The fragility of bones in diabetes can be attributed to cellular abnormalities, matrix interactions, immune and vascular changes, and musculoskeletal maladaptation to chronic hyperglycemia.

LANCET DIABETES & ENDOCRINOLOGY (2022)

Article Endocrinology & Metabolism

Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial

Aliya A. Khan, Mishaela R. Rubin, Peter Schwarz, Tamara Vokes, Dolores M. Shoback, Claudia Gagnon, Andrea Palermo, Claudio Marcocci, Bart L. Clarke, Lisa G. Abbott, Lorenz C. Hofbauer, Lynn Kohlmeier, Susanne Pihl, Xuebei An, Walter Frank Eng, Alden R. Smith, Jenny Ukena, Christopher T. Sibley, Aimee D. Shu, Lars Rejnmark

Summary: TransCon PTH demonstrated efficacy in maintaining normocalcemia and allowing independence from conventional therapy in individuals with hypoparathyroidism. The treatment also showed significant improvements in health-related quality of life and hypoparathyroidism-related symptoms.

JOURNAL OF BONE AND MINERAL RESEARCH (2023)

Article Endocrinology & Metabolism

Reduced Bone Mass and Increased Osteocyte Tartrate-Resistant Acid Phosphatase (TRAP) Activity, But Not Low Mineralized Matrix Around Osteocyte Lacunae, Are Restored After Recovery From Exogenous Hyperthyroidism in Male Mice

Eva Maria Woelfel, Franziska Lademann, Haniyeh Hemmatian, Stephane Blouin, Phaedra Messmer, Lorenz C. Hofbauer, Bjoern Busse, Martina Rauner, Katharina Jaehn-Rickert, Elena Tsourdi

Summary: Hyperthyroidism causes secondary osteoporosis by promoting bone resorption. Osteocytic osteolysis and elevated tartrate-resistant acid phosphatase (TRAP) activity were observed in hyperthyroid mice. The bone microarchitecture and turnover recovered after treatment, but the osteocytic osteolysis effects were not reversed.

JOURNAL OF BONE AND MINERAL RESEARCH (2023)

Review Medicine, General & Internal

Irisin and Bone in Sickness and in Health: A Narrative Review of the Literature

Elena Tsourdi, Athanasios D. Anastasilakis, Lorenz C. Hofbauer, Martina Rauner, Franziska Lademann

Summary: Irisin is a hormone-like myokine produced by skeletal muscle during exercise. It plays a role in the browning process, thermogenesis, and regulates the functions of osteoblasts, osteoclasts, and osteocytes. Recent studies have shown that serum irisin levels decrease with age and in conditions involving bone diseases. However, the validity and reproducibility of current methods of irisin measurement are under question.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Biology

Dickkopf1 fuels inflammatory cytokine responses

Nikolai P. Jaschke, Sophie Paehlig, Anupam Sinha, Timon E. Adolph, Maria Ledesma Colunga, Maura Hofmann, Andrew Wang, Sylvia Thiele, Julian Schwaerzler, Alexander Kleymann, Marc Gentzel, Herbert Tilg, Ben Wielockx, Lorenz C. Hofbauer, Martina Rauner, Andy Goebel, Tilman D. Rachner

Summary: This study reveals the cell-autonomous function of Dickkopf1 (DKK1) in controlling inflammatory responses and maintaining the elevated inflammatory tone of cancer cells. It is found that genetic DKK1 variants are linked to elevated cytokine production in healthy populations, and genetic deletion of DKK1 can ameliorate inflammation and disease trajectories in a mouse model.

COMMUNICATIONS BIOLOGY (2022)

Article Engineering, Biomedical

Osteocyte apoptosis and cellular micropetrosis signify skeletal aging in type 1 diabetes

Sofie Dragoun Kolibova, Eva Maria Woelfel, Haniyeh Hemmatian, Petar Milovanovic, Herbert Mushumba, Birgit Wulff, Maximilian Neidhardt, Klaus Pueschel, Antonio Virgilio Failla, Annegreet Vlug, Alexander Schlaefer, Benjamin Ondruschka, Michael Amling, Lorenz C. Hofbauer, Martina Rauner, Bjoern Busse, Katharina Jaehn-Rickert

Summary: Type 1 diabetes mellitus (T1DM) is associated with increased bone fragility. Our study found accelerated osteocyte apoptosis and local mineralization in T1DM patients, suggesting that T1DM speeds up bone aging and impairs its biomechanical competence. Dysfunction of the osteocyte network hampers bone remodeling and repair, contributing to the increased fracture risk in T1DM individuals.

ACTA BIOMATERIALIA (2023)

Article Endocrinology & Metabolism

Activation of b-adrenergic receptor signaling prevents glucocorticoid-induced obesity and adipose tissue dysfunction in male mice

Manuel Gado, Annett Heinrich, Denise Wiedersich, Katrin Sameith, Andreas Dahl, Vasileia I. Alexaki, Michael M. Swarbrick, Ulrike Baschant, Ingo Grafe, Nikolaos Perakakis, Stefan R. Bornstein, Martina Rauner, Lorenz C. Hofbauer, Holger Henneicke

Summary: This study demonstrates that activation of the sympathetic nervous system through cold exposure or selective I33-adrenergic receptor agonist can alleviate the adverse metabolic effects caused by chronic glucocorticoid exposure. Cold exposure preserves the function of brown adipose tissue and reverses white adipose tissue lipid accumulation, correcting obesity, hyperinsulinemia, and hyperglycemia caused by glucocorticoids.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2023)

Article Engineering, Biomedical

Rational engineering of glycosaminoglycan-based Dickkopf-1 scavengers to improve bone regeneration

Gloria Ruiz-Gomez, Juliane Salbach-Hirsch, Jan-Niklas Duerig, Linda Koehler, Kanagasabai Balamurugan, Sandra Rother, Sophie-Luise Heidig, Stephanie Moeller, Matthias Schnabelrauch, Giulia Furesi, Sophie Paehlig, Pedro M. Guillem-Gloria, Christine Hofbauer, Vera Hintze, M. Teresa Pisabarro, Joerg Rademann, Lorenz C. Hofbauer

Summary: The WNT signaling pathway is important for bone development and regeneration, and abnormalities in WNT ligands and inhibitors are associated with various bone diseases. This study focused on glycosaminoglycan (GAG) recognition by DKK1, a WNT inhibitor, and aimed to develop WNT signaling regulators. Through a multidisciplinary approach, researchers designed and synthesized GAG derivatives with improved neutralizing properties for DKK1. These derivatives showed increased WNT pathway activity and improved bone regeneration in experimental models. The findings suggest that rationally engineered GAG variants could be used as novel therapeutic approaches.

BIOMATERIALS (2023)

Article Biochemistry & Molecular Biology

Transferrin receptor 2 deficiency promotes macrophage polarization and inflammatory arthritis

Maria G. Ledesma-Colunga, Ulrike Baschant, Heike Weidner, Tiago C. Alves, Peter Mirtschink, Lorenz C. Hofbauer, Martina Rauner

Summary: In this study, the authors investigated the role of transferrin receptor 2 (Tfr2) in the pathogenesis of inflammatory arthritis. They found that Tfr2-deficient mice developed more severe joint inflammation and bone erosion compared to control mice. Further experiments suggested that Tfr2 deficiency promoted macrophage polarization towards a pro-inflammatory state, contributing to the progression of arthritis.

REDOX BIOLOGY (2023)

Article Endocrinology & Metabolism

Effects of adipocyte-specific Dkk1 deletion on bone homeostasis and obesity-induced bone loss in male mice

Souad Daamouch, Sylvia Thiele, Lorenz Hofbauer, Martina Rauner

Summary: The link between obesity and low bone strength is a significant medical concern. Previous research has shown that Dkk1, a Wnt inhibitor, is upregulated in bone tissue in obesity and drives obesity-induced bone loss. This study investigated the role of adipogenic Dkk1 in bone homeostasis and obesity-induced bone loss in mice. The results suggest that adipogenic Dkk1 plays a transient role in bone mass regulation during adolescence, but does not contribute to bone homeostasis or obesity-induced bone loss later in life.

ENDOCRINE CONNECTIONS (2023)

Article Medicine, General & Internal

Lipid Profile after Pharmacologic Discontinuation and Restoration of Menstruation in Women with Endometriosis: A 12-Month Observational Prospective Study

Athanasios D. Anastasilakis, Stergios A. Polyzos, Panagiotis A. Vorkas, Athina Gkiomisi, Maria P. Yavropoulou, Martina Rauner, Panagiotis Nikolakopoulos, Stergios Papachatzopoulos, Polyzois Makras, Spyridon Gerou, Lorenz C. Hofbauer, Andrea Palermo, Elena Tsourdi

Summary: Menstrual cessation affects lipid metabolism. This study evaluated the effects of goserelin-induced menstrual cessation and subsequent menstrual restoration on lipid metabolism. The results showed that levels of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and apolipoprotein A1 increased during menstrual cessation, but remained unchanged during menstrual restoration.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Endocrinology & Metabolism

Reduced Bone Regeneration in Rats With Type 2 Diabetes Mellitus as a Result of Impaired Stromal Cell and Osteoblast Function-A Computer Modeling Study

Mahdi Jaber, Lorenz C. Hofbauer, Christine Hofbauer, Georg N. Duda, Sara Checa

Summary: Bone regeneration is impaired in type 2 diabetes mellitus (T2DM), with alterations in MSC proliferation, migration, and osteoblast differentiation playing a significant role. Mechanical changes have minimal impact on reduced bone regeneration in T2DM. These findings have clinical implications for the treatment of bone fractures in patients with T2DM.

JBMR PLUS (2023)

Article Medicine, Research & Experimental

Deconstructing cellular senescence in bone and beyond

Lorenz C. Hofbauer, Franziska Lademann, Martina Rauner

Summary: Osteocytes, senescent cells implicated in bone loss disorders, have been shown to be effectively cleared through systemic senolysis, preventing age-related bone loss and mitigating bone marrow adiposity. Cell-specific senolysis in osteocytes alone had only a partial effect. Surprisingly, transplantation of senescent fibroblasts into young mice led to osteocyte senescence and bone loss. These findings on osteocyte senescence and the effects of remote senolysis suggest potential strategies against multisystem aging.

JOURNAL OF CLINICAL INVESTIGATION (2023)

暂无数据